Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. A. Hamidi, A. M. Szema, K. G. Dickman, S. Lyubsky, R. Z. Lin, Y. P. Jiang, S. Kort, S. I. Said (Northport, Stony Brook, United States Of America). Pulmonary arterial hypertension phenotype in VIP knockout mice. Eur Respir J 2006; 28: Suppl. 50, 3152

Member's Comments

No comment yet.

Related content which might interest you: Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH) Source: Annual Congress 2006 - Cellular mechanisms of airway disease Year: 2006 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43 Source: International Congress 2017 – Experimental PH Year: 2017 LATE-BREAKING ABSTRACT: KCNK3 dysfunction contributes to the development of pulmonary arterial hypertension – Characterization of Kcnk3 deficient rats Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Mice over-expressing the 5-HT transporter gene develop pulmonary hypertension Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension Year: 2004 MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Familial pulmonary arterial hypertension by KDR heterozygous loss of function Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019 Year: 2020 Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis. Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Contributions of TRPV4 to altered pulmonary vasoreactivity in mice with pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Macitentan modulates pulmonary mRNA levels of gremlin 1 in a rat model of pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 A novel murine model of severe pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Role of NFATc3 in chronic hypoxia induced pulmonary hypertension in neonatal mice Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Bosentan fails to prevent the development of pulmonary arterial hypertension in athymic rats exposed to chronic hypoxia Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Apelin improves cardiac output in patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Vasoactive intestinal peptide (VIP) markedly attenuates pulmonary hypertension in fawn-hooded rats Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Autoimmunity and pulmonary arterial hypertension: The role of leptin Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012